| Q35198054 | A cellular factor is required for transcription of vaccinia viral intermediate-stage genes. |
| Q33604728 | A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis |
| Q37126192 | A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging. |
| Q38049928 | African swine fever virus transcription |
| Q37341397 | Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters |
| Q34690881 | Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses |
| Q34301810 | Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression |
| Q33350226 | Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes |
| Q59349447 | Cutting Edge: Protection by Antiviral Memory CD8 T Cells Requires Rapidly Produced Antigen in Large Amounts |
| Q35611968 | Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling |
| Q38534549 | Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression |
| Q33639877 | Down regulation of gene expression by the vaccinia virus D10 protein. |
| Q35383164 | Expression profiling of the intermediate and late stages of poxvirus replication |
| Q45764815 | Expression, purification, and characterization of vaccinia virus-encoded RNA and poly(A) polymerases |
| Q35076980 | Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts |
| Q35058993 | Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression |
| Q33302240 | Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly |
| Q37110640 | Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes |
| Q37452102 | Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor |
| Q39877246 | Intermediate class of mRNAs in African swine fever virus. |
| Q36890933 | Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes |
| Q38299230 | Lsm proteins bind and stabilize RNAs containing 5' poly(A) tracts |
| Q36633867 | Modification of the cascade model for regulation of vaccinia virus gene expression: purification of a prereplicative, late-stage-specific transcription factor. |
| Q34330496 | Molecular chaperone Hsp90 is important for vaccinia virus growth in cells |
| Q36652907 | Mutational analysis of a predicted zinc-binding motif in the 26-kilodalton protein encoded by the vaccinia virus A2L gene: correlation of zinc binding with late transcriptional transactivation activity |
| Q36652885 | Overexpression, purification, and late transcription factor activity of the 17-kilodalton protein encoded by the vaccinia virus A1L gene |
| Q36225693 | Pervasive initiation and 3'-end formation of poxvirus postreplicative RNAs |
| Q38632221 | Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme |
| Q35853179 | Phenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor |
| Q36160688 | Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription |
| Q40850940 | Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function |
| Q35177770 | Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses |
| Q36406894 | Poxviruses: past, present and future. |
| Q45877926 | Prevention of murine breast cancer by vaccination with tumor cells modified by cytokine-producing recombinant vaccinia viruses |
| Q64063530 | Quantitative Temporal Proteomic Analysis of Vaccinia Virus Infection Reveals Regulation of Histone Deacetylases by an Interferon Antagonist |
| Q57469938 | RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog |
| Q34809962 | Regulation of gene expression by reiterative transcription |
| Q33839103 | Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase |
| Q34816747 | Regulation of viral transcription elongation and termination during vaccinia virus infection |
| Q34424934 | Restriction of vaccinia virus replication by a ced-3 and ced-4-dependent pathway in Caenorhabditis elegans |
| Q24620092 | Reverse genetics analysis of poxvirus intermediate transcription factors |
| Q38331191 | Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes |
| Q34780607 | Smallpox vaccines: targets of protective immunity |
| Q36621273 | Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant. |
| Q40064979 | The 5'-poly(A) leader of poxvirus mRNA confers a translational advantage that can be achieved in cells with impaired cap-dependent translation. |
| Q37547637 | The D10 decapping enzyme of vaccinia virus contributes to decay of cellular and viral mRNAs and to virulence in mice |
| Q45090422 | The cowpox virus host range gene, CP77, affects phosphorylation of eIF2 alpha and vaccinia viral translation in apoptotic HeLa cells |
| Q39590582 | The genome of fowlpox virus |
| Q33783723 | The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor. |
| Q40040916 | The vaccinia virus A18R protein plays a role in viral transcription during both the early and the late phases of infection |
| Q40577848 | The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. |
| Q58092266 | Translational control during poxvirus infection |
| Q24529142 | Vaccinia virus A30L protein is required for association of viral membranes with dense viroplasm to form immature virions |
| Q35628538 | Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression |
| Q30540518 | Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication |
| Q35847773 | Vaccinia virus gene A18R encodes an essential DNA helicase |
| Q24609947 | Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated |